Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (2065)

SortShow
Name Institution Why
Lewis Barry Silverman, M.D.Dana-Farber Cancer Institute Why?
Stephen Earl Sallan, M.D.Dana-Farber Cancer Institute Why?
Daniel J. DeAngelo, Ph.D., M.D.Dana-Farber Cancer Institute Why?
A. Thomas Look, M.D.Dana-Farber Cancer Institute Why?
Donna S. Neuberg, D.Sc.Harvard T.H. Chan School of Public Health Why?
Alejandro Gutierrez, M.D.Boston Children's Hospital Why?
Jon Christopher Aster, M.D.,Ph.D.Brigham and Women's Hospital Why?
David M. Langenau, Ph.D.Massachusetts General Hospital Why?
Scott A. Armstrong, M.D.,Ph.D.Dana-Farber Cancer Institute Why?
David Marc Weinstock, M.D.Dana-Farber Cancer Institute Why?
Richard M. Stone, M.D.Dana-Farber Cancer Institute Why?
Deborah Paula Waber, Ph.D.Boston Children's Hospital Why?
Lynda Marie Vrooman, M.D.Dana-Farber Cancer Institute Why?
Amir Tahmasb Fathi, M.D.Massachusetts General Hospital Why?
Stephen Charles Blacklow, Ph.D., M.D.Harvard Medical School Why?
Per Page    Page  of 138last Nextnext
Prev
Search Criteria
  • Precursor Cell Lymphoblastic Leukemia Lymphoma
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.